IRCT20230706058689N1招募中3 期
The effect of phoenix Dactylifera supplementary on fatigue in patients with multiple sclerosis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Having a history of MS for at least 3 months (based on the information in the patient's file)
- •Age 18 to 60 years
- •Absence of food and drug allergy (date products)
- •Obtaining a score of 28 or more in severe measurement (FSS)
- •Obtaining informed consent
- •Absence of pregnancy (pregnancy during the study period or decision to become pregnant at the beginning of the study)
排除标准
- •The use of antidepressants
- •The use of other medications effective in relieving fatigue (Ritalin, Pemoline, Amantadine)
研究者
相似试验
已完成
不适用
Phoneix Dactylifera pollen and delayed-onset muscle soreness indicesDelayed-onset muscle soreness.Primary disorders of musclesIRCT20190103042219N2Central Tehran Branch, Islamic Azad University36
尚未招募
3 期
The effect of Phoenix Dactylifera Spathe vaginal gel on sexual function and Vaginal Atrophy in Menopausal womeSexual function in menopauseVaginal atrophy in menopause.Menopausal and other perimenopausal disordersIRCT20210517051331N1Ahvaz University of Medical Sciences110
已完成
不适用
The effect of the supplementary capsule containing lutein on visual function in college student athletesot applicableJPRN-UMIN000045933Juntendo University School of Health and Sports Science30
已完成
不适用
Effect of Prickly Pear fruit consumption on postprandial blood lipids and Physiological ResponsesBroadly-hypercholesterolemiaBroadly-HyperlipidemiaBroadly- risk factors of Metabolic syndromeBroadly- risk factors of Cardiovascular diseaseDiet and Nutrition - Other diet and nutrition disordersCardiovascular - HypertensionCardiovascular - Other cardiovascular diseasesMetabolic and Endocrine - Other metabolic disordersMetabolic and Endocrine - Metabolic disordersACTRN12618001560280Faculty of Health18
已完成
不适用
The effect of a disease-specific supplement on the postprandial plasma glucose response in type 2 diabetic patients at baseline and after 6 and 12 weeks of supplementatioDiabetes Mellitus type II (DM type II)Nutritional, Metabolic, EndocrineDiabetesISRCTN86065299umico Research B.V. (The Netherlands)34